Home / Market News / $ODTX

$ODTX news and market catalysts

The 4 most recent market catalysts affecting $ODTX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 0 high impact 1 bullish 0 bearish Biotechnology
Oct 12, 2026 Corporate Catalyst Neutral Impact 65
UBS Initiates Coverage On Odyssey Therapeutics with Buy Rating, Announces Price Target of $27
UBS analyst Alice Nettleton has initiated coverage on Odyssey Therapeutics (ODTX) with a 'Buy' rating and set a price target of $27. This event is significant for ODTX as new analy…
Oct 9, 2026 Corporate Catalyst Neutral Impact 65
Raymond James Initiates Coverage On Odyssey Therapeutics with Outperform Rating, Announces Price Target of $42
Raymond James analyst Thomas Deal initiated coverage on Odyssey Therapeutics (ODTX) with an Outperform rating and a $42 price target. This event is significant as new analyst cover…
Aug 27, 2026 Corporate Catalyst Neutral Impact 65
HC Wainwright & Co. Initiates Coverage On Odyssey Therapeutics with Buy Rating, Announces Price Target of $44
HC Wainwright & Co. analyst Emily Bodnar has initiated coverage on Odyssey Therapeutics (ODTX) with a 'Buy' rating and a price target of $44. This event is significant as new analy…
Aug 7, 2026 Corporate Catalyst Bullish Impact 55
JP Morgan Maintains Overweight on Odyssey Therapeutics, Raises Price Target to $29
JP Morgan analyst Brian Cheng maintained an 'Overweight' rating on Odyssey Therapeutics (ODTX) and raised the price target from $26 to $29. This action signals a continued positive…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.